Approval · Notice of Compliance 23058 · 2019
VASCEPA: Notice of Compliance 23058
Issued December 30, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23058
- Date
- December 30, 2019
- Company
- Hls Therapeutics IncEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VASCEPA | 02495244 | Marketed |
Medicinal ingredients
- ICOSAPENT ETHYL 1 G per CAP